FDA 483 OBSERVATION · #162 OF 1,945 MOST-CITED

Investigator non-compliance with agreement/plan/regulations

FDA cited this observation 195 times across 191 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices195
BY FISCAL YEAR
FY202619
FY202521
FY202413
FY202312
FY20227
FY20218
FY202015
FY201915
FY201835
FY201725
FY201625

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0.1× the rate of the average FDA-cited firm (1.1% vs 7.8%), across 191 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

An investigation was not conducted in accordance with the investigational plan.

Roderick H. Tung, M.D. · Phoenix, Arizona · Devices · 2026-09-14

An investigation was not conducted according to the signed agreement, investigational plan and applicable FDA regulations.

Mark Clemens M.D. · Houston, Texas · Devices · 2026-08-06

An investigation was not conducted according to the investigational plan.

Endovascular Engineering, Inc · Menlo Park, California · Devices · 2026-07-21

An investigation was not conducted according to the investigational plan.

Benjamin D. Elder, MD, PhD · Rochester, Minnesota · Devices · 2026-03-27

An investigation was not conducted according to the signed agreement and investigational plan.

Terence T. Sio, M.D., M.S. · Phoenix, Arizona · Devices · 2026-03-23

An investigation was not conducted according to the signed agreement, investigational plan and applicable FDA regulations.

Rishi K. Wadhwa, M.D. · Shreveport, Louisiana · Devices · 2026-03-20

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Medical devices →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →